FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Inadequate Lab Controls Top API Inspection Citation: FDA

[ Price : $8.95]

CDER branch chief Alicia M. Mozzachio says inadequate lab controls leads FDAs list of common violations seen at international acti...

Guidance on Labeling Patient Counseling Section

[ Price : $8.95]

FDA issues a draft guidance to help applicants develop the Patient Counseling Information section in drug labeling.

FDA Posts August NADA, ANADA Approvals

[ Price : $8.95]

Federal Register Final rule: FDA amends the animal drug regulations to reflect August approvals.

Panel to Discuss Janssen NDA for Hepatitis C

[ Price : $8.95]

Federal Register Notice: FDAs Antiviral Drugs Advisory Committee will meet 10/24 to discuss a Janssen NDA for simeprevir to treat ...

FDA Approves Suns Generic Prevacid

[ Price : $8.95]

FDA approves a Sun Pharmaceutical Industries ANDA for a generic version of Prevacid (lansoprazole) delayed-release capsules USP, 1...

Info On CLIA Requests Sent to OMB

[ Price : $8.95]

Federal Register Notice: FDA submits a proposed collection of information on requests for Clinical Laboratory Improvement Amendmen...

Panel to Discuss Gilead Sciences NDA for Hepatitis C

[ Price : $8.95]

Federal Register Notice: FDAs Antiviral Drugs Advisory Committee will meet 10/25 to discuss a Gilead Sciences NDA for treating chr...

FDA Clears Lumenis Skin Resurfacing Laser Module

[ Price : $8.95]

FDA grants 510(k) clearance to Lumenis Ltd. for the ResurFX, a fractional non-ablative laser module for skin resurfacing.

Woodcock to Personally Oversee Latest Drug Quality Push

[ Price : $8.95]

CDER director Janet Woodcock says FDAs latest push to advance pharmaceutical quality will be directed by her personally as part of...

Blood Panel to Discuss MP Biomedicals BLA

[ Price : $8.95]

Federal Register Notice: FDAs Blood Products Advisory Committee will meet 11/1 to discuss MP Biomedicals BLA for a Western blot in...